Zariana Nikolova

Zariana Nikolova

Company: Bristol Myers Squibb

Job title: Executive Director

Seminars:

CC-90011, a Potent, Oral, & Reversible LSD1 Inhibitor 11:00 am

CC-90011, a potent, oral, and reversible LSD1 inhibitor, has been shown to be very well tolerated in patients With follow-up as long as 44 cycles of treatment, no new AEs were identified; most TEAEs were mild, reversible, and easily manageable by short dose interruptions and dose modifications Review early evidence of antitumor activity that was…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.